Primary Diagnosis with Digital Pathology Systems and Whole Slide Images: What Every Pathologist Needs to Know, Why It Will Be Disruptive, and How Innovative Pathology Groups Are Already Making Money with DP
Webinar was held
Thursday, August 17, 2017
Momentous times are ahead for all anatomic pathologists. That’s because digital pathology (DP) and whole slide images (WSI) are poised to revolutionize the profession. Experts agree: the FDA’s long-awaited clearance of a DP system for use in primary diagnosis earlier this year is the trigger event for a wave of clinical, operational, financial, and professional transformation.
The FDA’s decision confronts every pathologist and pathology practice administrator with a fundamental question that comes with high stakes: how quickly will digital pathology systems and whole slide imaging come to my group practice or medical laboratory?
To help you and your practice administrator answer this question, DarkDaily.com has brought together four experts in digital pathology to give you a concise and up-to-date assessment of this technology, how it is being currently used, and what you and your practice administrator need to know to make informed decisions about when and how your pathology group or laboratory should move ahead to introduce digital pathology services to your hospital, your client physicians, and patients in your community.
The four experts present during a timely webinar titled, “Primary Diagnosis with Digital Pathology Systems and Whole Slide Images: What Every Pathologist Needs to Know, Why It Will Be Disruptive, and How Innovative Pathology Groups Are Already Making Money with DP.” This 90-minute webinar took place on Thursday, August 17, 2017.
This is concentrated learning, focused on the essential information you need, in order to understand:
- The current capabilities of DP and WSI, and ways your group can make money with them today
- How quickly the technology is expected to change so that tools, like algorithm-driven image analysis, can improve diagnostic accuracy while boosting the productivity of your pathologists, and
- Real-world examples of two pathology groups sharing how they are already using DP and WSI to deliver greater clinical value while increasing revenue and protecting the incomes of their pathologists
Your chair and moderator for the webinar is Keith Kaplan, MD, Founder of The Digital Pathology Blog. He is nationally recognized as one of the pathology profession’s thought leaders on all things involving web-based services, digital technologies, and new capabilities in molecular and genetic diagnostics that help pathologists deliver more clinical value with surgical pathology services.
Providing you with an up-to-the-minute lay of the land about digital pathology systems and whole slide imaging is Liron Pantanowitz, MD, Professor of Pathology and Biomedical Informatics at the University of Pittsburgh Medical Center. He discusses the current capabilities of DP and WSI, with examples of their effective use in clinical care today. What will be invaluable for you and your practice administrator are his insights about the technology advances and new capabilities that are heading to the clinical market in the near future.
This is an important point. During this webinar, you won’t only learn about what DP and WSI are today. You’ll get informed opinions as to the technologies ready to come to market that will allow your group’s digital pathology system to support technologies like guided digital image analysis and multi-spectral image analysis, that will not only allow pathologists to make earlier and more accurate diagnoses from smaller quantities of tissue, but will also increase pathologist productivity and contribute to improved remuneration for your group and your partners.
Pantanowitz also has vital insights on how digital pathology will make it possible for your group’s subspecialists to generate more case referrals from the region, the nation, and even internationally. For example, UPMC has a flourishing digital pathology relationship with a major lab in China and those cases come with cash payments (eliminating the complexities of billing a health insurer).
And the real-word insights don’t stop there. The next presentations are actual case studies by pathology groups like yours that are using DP and WSI to deliver enriched diagnostic services to referring physicians, while winning new clients and generating new sources of revenue. That is what is happening at ClearPathDerm in Dayton, Ohio. This group has gone beyond the use of a DP system for the standard tasks. It has an “all-in” digital strategy whereby it is introducing additional informatics capabilities to referring physicians that not only support a robust TC-PC business, but also allow a physician to review images on an iPad or tablet device and immediately refer the case to one of the ClearPathDerm’s subspecialist pathologists.
Just some of what you’ll take away from this indispensable session:
- Understand what the FDA’s clearance of the Philips IntelliSite Pathology Solution for primary diagnosis allows and what it does not
- Identify useful steps your pathology group can take now to evaluate the benefits versus costs of acquiring and using a digital pathology system
- Learn specific ways that pathology labs are now using DP and WSI to build stronger clinical bonds with referring physicians, leading to increased case referrals and more revenue
- Hear actual case studies about how an innovative pathology lab is expanding its TC-PC relationships because of DP and WSI added value for client physicians
- Learn why DP and WSI are already the cornerstone that some community pathology groups use to increase subspecialty referrals in their region
- Discover the hurdles to adoption and use of digital pathology systems and whole slide imaging, and how to overcome these challenges
- Relate the action steps your pathology team should take to assess DP systems and develop a viable return-on-investment (ROI) while increasing practice revenue and pathologist income
Speedy adoption of digital pathology systems and WSI can give your pathology group considerable competitive advantage. It can mean stronger relationships with referring physicians, more case referrals, expanded market share, increased revenue, and greater pathologist compensation for you and your colleagues. In these financially-stressful times, those are wonderful outcomes and they do help preserve and increase your annual income. Don’t wait, order this important webinar now!
Keith Kaplan, MD, Chief Medical Officer, Corista, Concord, MA.
Dr. Kaplan is a native of Chicago and a graduate of Michigan State University. He is a graduate of Northwestern University Feinberg School of Medicine and completed residency training in anatomic and clinical pathology at Walter Reed Army Medical Center, Washington, DC. While at Walter Reed, Dr. Kaplan was named Resident of the Year, and in conjunction with the Armed Forces Institute of Pathology, Dr. Kaplan founded and directed the Army Telepathology Program. This Program connected 25 hospitals internationally for consultation via telepathology. Dr. Kaplan also served as the Medical Director and Consulting Pathologist of Laboratory Services at Keller Army Hospital in West Point, New York.
Dr. Kaplan is board certified in anatomic and clinical pathology. His subspecialty interests include gastrointestinal and hepatic pathology, cytopathology and pathology informatics as well as research interests in gastrointestinal and hepatobiliary pathology, hyperspectral imaging, image analysis and the use of Web 2.0 tools in pathology. He has authored over 60 peer-reviewed scientific articles, book chapters, editorials and scientific abstracts and frequently lectures at both national and international meetings on topics related to pathology informatics.
Dr. Kaplan currently serves as a member of the College of American Pathologists and the American Society of Cytopathology as well as the American Pathology Foundation. Dr. Kaplan has previously served as a member of the College of American Pathologists Informatics Committee, Standards Committee, and Instrumentation Resource Committee and as co-chair of the American Telemedicine Association Telepathology Special Interest Group and as a board member for the Digital Pathology Association.
Liron Pantanowitz, MD, Professor of Pathology and Biomedical Informatics at the University of Pittsburgh Medical Center, Pittsburgh, PA.
Dr. Liron Pantanowitz is a Professor of Pathology and Professor of Biomedical Informatics at the University of Pittsburgh in the USA. He is certified in Anatomical Pathology, Clinical Pathology, Cytopathology and Clinical Informatics by the American Board of Pathology. He is the Director of Pathology Informatics and Director of the Pathology Informatics Fellowship Program and the University of Pittsburgh Medical Center (UPMC). He is also the Director of Cytopathology at UPMC Shadyside. Dr. Pantanowitz is an Editor-in-Chief of the Journal of Pathology. He serves on key committees for the College of American Pathology and Digital Pathology Association. He has published extensively in the field of digital pathology.
Dan Angress, President, Angress Consulting, LLC, Los Angeles, CA.
Over the course of his 30+ year career, Dan Angress has achieved a track record of starting, building, growing, and improving the profitability, performance, and value of companies in the healthcare industry with significant experience in laboratory diagnostics and software. Angress is particularly effective in taking complex, technically dense ideas and positioning them in a simple way to a target audience, building and differentiating brands in the market, and streamlining operations for efficiency, through methodical process improvement and empowerment of managers in each department. He has in-depth knowledge of healthcare practices, procedures and laws, regulations and guidelines pertaining to healthcare, with capabilities extending across the spectrum of healthcare including laboratory, pathology, software LIS and digital pathology, IT, medical devices, personalized medicine, pharma, and radiology.
Isaac R. Grindeland, MD, Gastrointestinal Pathology, Incyte Diagnostics, Spokane Valley, WA.
Dr. Grindeland joined Incyte Diagnostics in 2014. He is board certified in anatomic and clinical pathology and completed a
fellowship in gastrointestinal pathology. Dr. Grindeland currently serves as the laboratory medical director at Pullman
Regional Hospital in Pullman, WA; Gritman Medical Center in Moscow, ID; and Whitman Hospital and Medical Center in Colfax, WA.
Dr. Grindeland oversees three laboratories at three critical access hospitals in the Palouse region of Washington. He is actively involved in multiple committees at the various hospitals on subjects that include patient safety, infection prevention, therapeutics, antimicrobial stewardship, critical care/medicine, medical patient care, and pharmacy. In 2017, he was elected to Pullman Regional Hospital’s medical executive committee. Dr. Grindeland also is a guest lecturer for the WWAMI medical students at the University of Idaho.